Unknown

Dataset Information

0

Preliminary association of circulating tumor cells (CTCs) pre- and post-AdHER2 dendritic cell vaccination with overall survival in patients with metastatic HER2+ solid tumors

ABSTRACT:

SUBMITTER: Tomita Y 

PROVIDER: S-EPMC4645504 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.
| S-EPMC11735936 | biostudies-literature
Clinical Dendritic Cell Vaccination for Patients With Solid Tumors
| 2101939 | ecrin-mdr-crc
Unknown Author Correction: Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models.
| S-EPMC11923157 | biostudies-literature
Unknown A novel liquid biopsy assay for detection of <i>ERBB2</i> (HER2) amplification in circulating tumor cells (CTCs).
| S-EPMC11456801 | biostudies-literature
Unknown Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.
| S-EPMC12330086 | biostudies-literature
Unknown Trastuzumab Deruxtecan: Changing the Destiny of HER2 Expressing Solid Tumors.
| S-EPMC8125530 | biostudies-literature
Unknown HER2-low expression in patients with advanced or metastatic solid tumors.
| S-EPMC11670753 | biostudies-literature
Unknown Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.
| S-EPMC4760342 | biostudies-literature
Unknown Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment.
| S-EPMC6475716 | biostudies-literature
Unknown Circulating giant macrophages as a potential biomarker of solid tumors.
| S-EPMC3948254 | biostudies-literature